Close Menu

Pathogenetix

Jonathan Rothberg has resigned from his position as CEO of Life Technologies' Ion Torrent business, according to a filing with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.

Bacterial typing systems developer PathoGenetix has hired Paul Krassnoff to be director of manufacturing. In this post, he will develop production and quality assurance systems for the firm's Genome Sequence Scanning System.

PathoGenetix has raised $7.5 million in a second closing of a Series B financing round, bringing its total raised in the round to $11.5 million.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PathoGenetix today announced it has raised $7.5 million in a second closing of a Series B financing round, bringing the total raised in the round to $11.5 million.

The company, formerly called US Genomics, will use the funding to complete development of its system for identifying pathogens in complex biological samples, which is scheduled for commercial release in 2012.

The company, once called US Genomics, will use the funds to complete development of its first commercial systems for identifying pathogens in complex biological samples.

In an SEC filing, the company, which had been called US Genomics, is targeting $1.8 million.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.